review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.7326/0003-4819-98-6-958 |
P698 | PubMed publication ID | 6344712 |
P50 | author | King K. Holmes | Q90437732 |
P2093 | author name string | Corey L | |
Brown ZA | |||
Adams HG | |||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sexual transmission | Q45349134 |
genital herpes | Q7476596 | ||
P304 | page(s) | 958-972 | |
P577 | publication date | 1983-06-01 | |
P1433 | published in | Annals of Internal Medicine | Q564416 |
P1476 | title | Genital herpes simplex virus infections: clinical manifestations, course, and complications | |
P478 | volume | 98 |
Q57076555 | 4 Herpes simplex virus infection in pregnancy |
Q45796499 | A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection |
Q35914367 | A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens |
Q45324468 | A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease |
Q36397612 | A herpes simplex virus 2 glycoprotein D mutant generated by bacterial artificial chromosome mutagenesis is severely impaired for infecting neuronal cells and infects only Vero cells expressing exogenous HVEM. |
Q35648857 | A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes |
Q30429126 | A rapid and simple isothermal nucleic acid amplification test for detection of herpes simplex virus types 1 and 2. |
Q40558932 | A retrospective clinical, laboratory and outcome analysis in 43 cases of acute aseptic meningitis |
Q35615364 | A review of famciclovir in the management of genital herpes |
Q40210971 | A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model |
Q34291342 | Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy |
Q69633728 | Acquired immunodeficiency syndrome manifested by chronic primary genital herpes |
Q70176360 | Acquisition of neonatal HSV-1 infection from a paternal source contact |
Q67912341 | Acute Urinary Retention Secondary to Herpes Simplex Meningitis |
Q33933248 | Acute infection with human immunodeficiency virus presenting with neurogenic urinary retention |
Q68338044 | Acute urinary retention in herpes genitalis infection urodynamic evaluation |
Q42947942 | Acute urinary retention preceding skin manifestations of genital herpes by 8 days |
Q38078826 | Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management |
Q40138670 | Acyclovir A Review of its Pharmacodynamic Properties and Therapeutic Efficacy |
Q33583052 | Acyclovir in first attacks of genital herpes and prevention of recurrences |
Q40081290 | Acyclovir: New era in antiviral chemotherapy |
Q40843184 | Advances in the treatment of herpesvirus infection: the role of famciclovir |
Q33850188 | Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission |
Q37860814 | An early event in the herpes simplex virus type-2 replication cycle is sufficient to induce Chlamydia trachomatis persistence |
Q39238300 | An overview application of silver nanoparticles in inhibition of herpes simplex virus. |
Q33737719 | An overview of sexually transmitted diseases. Part I. |
Q44911650 | Analysis of genomic polymorphism among herpes simplex virus type 2 isolates from four areas of Japan and three other countries |
Q52664441 | Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo. |
Q36978882 | Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes. |
Q40938400 | Antiviral chemotherapy in genital herpes simplex virus infections |
Q24234315 | Antiviral therapy for genital herpes for prevention of HIV transmission |
Q94355501 | Antiviral therapy for genital herpes for prevention of HIV transmission |
Q33936755 | Are reported stress and coping style associated with frequent recurrence of genital herpes? |
Q27489376 | Aseptic Meningitis and Viral Myelitis |
Q36543596 | Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory |
Q33856050 | Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes |
Q45881313 | Atypical Presentations of Herpes Simplex Virus Infection |
Q45835831 | Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2. |
Q45778248 | Autopsy findings in two cases of neonatal herpes simplex virus infection: detection of virus by immunohistochemistry, in situ hybridization and the polymerase chain reaction |
Q43822740 | Benign aseptic (Mollaret's) meningitis after genital herpes |
Q36625969 | Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection. |
Q37999153 | Chancroid and the role of genital ulcer disease in the spread of human retroviruses. |
Q42938618 | Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88. |
Q34193041 | Chemotherapy for herpes simplex virus infections |
Q37863305 | Chlamydia trachomatis enters a viable but non-cultivable (persistent) state within herpes simplex virus type 2 (HSV-2) co-infected host cells |
Q45763302 | Clear detection and typing of herpes simplex virus types 1 and 2 by an indirect ELISA assay: comparison with three different combined methods--capture ELISA, restriction enzymes, and polymerase chain reaction. |
Q37380356 | Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes |
Q36729580 | Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection |
Q69610617 | Clinical approach to urethritis, mucocutaneous lesions, and inguinal lymphadenopathy in homosexual men |
Q33577281 | Clinical correlates of herpes simplex virus viremia among hospitalized adults |
Q37229605 | Clinical study in genital herpes: natural Gene-Eden-VIR/Novirin versus acyclovir, valacyclovir, and famciclovir |
Q64255293 | Co-infection of Herpes Simplex Virus Type 2 and HIV Infections among Pregnant Women in Ibadan, Nigeria |
Q30417946 | Comparative clinical evaluation of the IsoAmp(®) HSV Assay with ELVIS(®) HSV culture/ID/typing test system for the detection of herpes simplex virus in genital and oral lesions |
Q33951277 | Comparative performance of herpes simplex virus type 1-specific serologic assays from MRL and Meridian Diagnostics |
Q37255330 | Comparative studies of types 1 and 2 herpes simplex virus infection of cultured normal keratinocytes |
Q67486959 | Comparison of immunocytochemistry and in situ hybridization in the cytodiagnosis of genital herpetic infection |
Q35331493 | Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences |
Q37232489 | Comparison of standard culture methods, a shell vial assay, and a DNA probe for the detection of herpes simplex virus |
Q37278010 | Comparison of the Scott Selecticult-HSV kit with conventional culture and direct immunoperoxidase staining for detection of herpes simplex virus in cultures of clinical specimens |
Q37199777 | Comparison of the detection of herpes simplex virus in direct clinical specimens with herpes simplex virus-specific DNA probes and monoclonal antibodies |
Q36170672 | Contemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses |
Q89965378 | Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection |
Q36630996 | Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding |
Q22306018 | Current treatment options to prevent perinatal transmission of herpes simplex virus |
Q33932423 | Cutaneous herpes simplex infections |
Q35199402 | Cytodiagnosis of herpes simplex mastitis: Report of a rare case |
Q45026813 | Demonstration of either endogenous recurrence or exogenous reinfection by resiriction endonuclease cleavage analysis of herpes simplex virus from patients with recrudescent genital herpes |
Q37139285 | Design, synthesis and antiviral activity studies of schizonepetin derivatives. |
Q35328407 | Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy |
Q36544583 | Detection and typing of herpes simplex viruses by using recombinant immunoglobulin fragments produced in bacteria |
Q36884252 | Detection of asymptomatic herpes simplex virus infections after vaccination |
Q37224689 | Detection of asymptomatic initial herpes simplex virus (HSV) infections in animals immunized with subunit HSV glycoprotein vaccines |
Q37149121 | Detection of herpes simplex virus DNA from genital lesions by in situ hybridization |
Q37189638 | Detection of herpes simplex virus by the Kodak SureCell Herpes Test |
Q37905045 | Detection of herpesvirus cervicovaginitis by a sequential Papanicolaou--immunoperoxidase technique |
Q37146168 | Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. |
Q58609061 | Development of disease and immunity at the genital epithelium following intrarectal inoculation of male guinea pigs with herpes simplex virus type 2 |
Q35531465 | Diagnosis of genital herpes by real time PCR in routine clinical practice |
Q37136139 | Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population |
Q45807317 | Diagnosis of oral herpes simplex virus infections: Practical aspects of viral culture |
Q45731556 | Differences in laboratory findings for cerebrospinal fluid specimens obtained from patients with meningitis or encephalitis due to herpes simplex virus (HSV) documented by detection of HSV DNA. |
Q36236667 | Differential association of ureaplasma species with non-gonococcal urethritis in heterosexual men. |
Q39009035 | Dynamic modeling of herpes simplex virus type-2 (HSV-2) transmission: issues in structural uncertainty |
Q97646481 | Dynamics of HSV-2 infection with a therapeutic vaccine |
Q40069410 | Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis |
Q45833448 | Effects of long-term acyclovir chemosuppression on serum IgG antibody to herpes simplex virus |
Q52561266 | Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition. |
Q36517783 | Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women |
Q38397126 | Epidural anaesthesia for caesarean section in patients with active recurrent genital herpes simplex infections: a retrospective review |
Q31028568 | Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials |
Q24187642 | Episodic therapy for recurrent genital herpes in non-immunocompromized adults |
Q35530369 | Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. |
Q37879348 | Etiology of nongonococcal nonchlamydial urethritis |
Q30654285 | Evaluation of ELVIS HSV ID/Typing System for the detection and typing of herpes simplex virus from clinical specimens |
Q37269262 | Evaluation of a commercial enzyme-linked immunosorbent assay for detection of herpes simplex virus antigen |
Q37278189 | Evaluation of a commercial enzyme-linked immunosorbent assay for the detection of herpes simplex virus |
Q40190649 | Evaluation of a rapid latex slide agglutination test for herpes simplex virus as a specimen screen and culture identification method |
Q47690917 | Evaluation of anti-HSV-2 activities of Barleria lupulina and Clinacanthus nutans |
Q45286596 | Evaluation of some pyrazoloquinolines as inhibitors of herpes simplex virus type 1 replication |
Q37266692 | Evaluation of the virocult transport tube for isolation of herpes simplex virus from clinical specimens |
Q33959969 | Evaluation of three glycoprotein G2-based enzyme immunoassays for detection of antibodies to herpes simplex virus type 2 in human sera |
Q43572238 | Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial |
Q40918319 | Female genital tract discharge |
Q39627155 | First-episode, recurrent, and asymptomatic herpes simplex infections. |
Q45783859 | Frequency and reactivation of nongenital lesions among patients with genital herpes simplex virus |
Q37364727 | Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment |
Q33638754 | Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model |
Q37886701 | From virus to vaccine: recombinant mammalian cell lines as substrates for the production of herpes simplex virus vaccines |
Q30235026 | Genital Herpes: Insights into Sexually Transmitted Infectious Disease |
Q28262599 | Genital herpes |
Q83289688 | Genital herpes |
Q77803098 | Genital herpes complicating pregnancy |
Q42946571 | Genital herpes diagnosed by cervical cytology |
Q33750736 | Genital herpes evaluation by quantitative TaqMan PCR: correlating single detection and quantity of HSV-2 DNA in cervicovaginal lavage fluids with cross-sectional and longitudinal clinical data |
Q36029499 | Genital herpes in Canada: Deciphering the hidden epidemic |
Q41349366 | Genital herpes simplex infection in women |
Q37999154 | Genital herpes simplex virus infections |
Q33614235 | Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States |
Q74752054 | Genital herpes--how much of a public-health problem? |
Q39519630 | Genital herpes. How to relieve patients' physical and psychological symptoms |
Q43457575 | Genital herpes. Recommendations for comprehensive care |
Q40828445 | Genital herpes. Type-specific antibodies for diagnosis and management |
Q69801208 | Genital herpes: does knowledge lead to action? |
Q40782518 | Genital herpes: natural history and treatment of acute episodes |
Q45756364 | Genital recurrent infection occurring 6 months after meningitis due to the same herpes simplex virus type 2 (HSV-2) strain evidence by restriction endonuclease analysis |
Q91384445 | Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published epidemiological data |
Q33650105 | Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer |
Q34212799 | Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the |
Q28595739 | HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway |
Q37262110 | Healthcare seeking and sexual behavior among patients with symptomatic newly acquired genital herpes |
Q68158083 | Herpes Genitalis |
Q28067618 | Herpes Genitalis: Diagnosis, Treatment and Prevention |
Q38743245 | Herpes Mastitis: Diagnosis and Management |
Q21562177 | Herpes Simplex Virus 2 ICP0− Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine |
Q57269717 | Herpes Simplex Virus Infections in Solid Organ Transplant Recipients |
Q34266498 | Herpes Simplex Virus Type 1 Is the Prevailing Cause of Genital Herpes in the Tel Aviv Area, Israel |
Q37058139 | Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features |
Q43597925 | Herpes diagnostic tests and their use. |
Q36624483 | Herpes in pregnancy |
Q33935057 | Herpes latency, meningitis, radiculomyelopathy and disseminated infection. |
Q77803093 | Herpes management and prophylaxis |
Q38672996 | Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes |
Q55067552 | Herpes simplex encephalitis: a review. |
Q35891431 | Herpes simplex mastitis: Case report and review of the literature |
Q77304582 | Herpes simplex virus |
Q36865265 | Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus |
Q35767424 | Herpes simplex virus 2 infection rate and necessity of screening during pregnancy: a clinical and seroepidemiologic study |
Q40844439 | Herpes simplex virus encephalitis in Peru: a multicentre prospective study. |
Q36445515 | Herpes simplex virus encephalitis in children |
Q42272329 | Herpes simplex virus in solid organ transplantation |
Q33948597 | Herpes simplex virus infections |
Q44285124 | Herpes simplex virus infections |
Q72401503 | Herpes simplex virus infections |
Q40782534 | Herpes simplex virus infections during the decade since the licensure of acyclovir |
Q36699405 | Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes |
Q35857276 | Herpes simplex virus latency-associated transcript sequence downstream of the promoter influences type-specific reactivation and viral neurotropism |
Q45770688 | Herpes simplex virus type 2 infection associated with urinary retention in the absence of genital lesions |
Q35873842 | Herpes simplex virus type 2 inhibition of Fas ligand expression |
Q34464387 | Herpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons |
Q41717714 | Herpes simplex virus-2 infection. An emerging disease? |
Q28236882 | Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding |
Q96231075 | Herpes simplex virus: global infection prevalence and incidence estimates, 2016 |
Q34743418 | Herpes simplex viruses 1 and 2. |
Q33660084 | Herpes vaccine |
Q39217722 | Herpesvirus infections in pregnancy: risks to embryo, fetus, and neonate. |
Q41046263 | Herpesvirus infections of the vulva |
Q36717602 | Human antibodies from combinatorial libraries. |
Q40855453 | Human cancer: molecular genetic and viral concepts and their influence in cytodiagnosis |
Q71954670 | Human leukocyte interferon-alpha in cream for the management of genital herpes in Asian women: a placebo-controlled, double-blind study |
Q69832268 | Humoral antibody response in patients with herpes genitalis: analysis of factors influencing the pattern of disease |
Q36852943 | Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine |
Q35089985 | Hyperaesthesia following genital herpes: a case report |
Q35111489 | Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursors |
Q37393772 | Idiopathic urethritis in young men in the United States: prevalence and comparison to infections with known sexually transmitted pathogens |
Q44437769 | IgG subclass of anti-HSV antibodies following neonatal HSV infections |
Q33595097 | Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs |
Q39726771 | Immunologic basis for increased susceptibility of the neonate to infection |
Q41687590 | Immunopathogenesis of herpetic ocular disease |
Q34562540 | Impact of asymptomatic Herpes simplex virus-2 infection on T cell phenotype and function in the foreskin |
Q45369995 | In vitro anti-herpes simplex virus activity of 1,2,4,6-tetra-O-galloyl-β-D-glucose from Phyllanthus emblica L. (Euphorbiaceae). |
Q35906911 | Incidence of Co-Infections of HIV, Herpes Simplex Virus Type 2 and Syphilis in a Large Cohort of Men Who Have Sex with Men in Beijing, China |
Q35066312 | Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis |
Q59350361 | Increased frequency of virus shedding by herpes simplex virus type 2-infected guinea pigs in the absence of CD4+ T lymphocytes |
Q35569595 | Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes |
Q77802801 | Infection and spread of alphaherpesviruses in the nervous system |
Q36333902 | Infective Agents in the Central Nervous System |
Q35575396 | Interferon in the prevention of genital herpes recurrence |
Q35656655 | Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme |
Q24201451 | Interventions for men and women with their first episode of genital herpes |
Q38941189 | Interventions for men and women with their first episode of genital herpes. |
Q43775536 | Intrauterine latent herpes simplex virus infection: I. Spontaneous abortion |
Q40943318 | Iontophoresis for enhancing penetration of dermatologic and antiviral drugs |
Q35530758 | Is HSV serology useful for the management of first episode genital herpes? |
Q33934358 | Laboratory techniques in the diagnosis of herpes simplex infection |
Q63740172 | Large, stable, contemporary interspecies recombination events in circulating human herpes simplex viruses |
Q94291182 | Maladies à herpétoviridés: prévention et traitement: Partie 2. Epidémiologie et immunologie |
Q37178782 | Male circumcision for the prevention of HSV-2 and HPV infections and syphilis |
Q37837623 | Male non-gonococcal urethritis: From microbiological etiologies to demographic and clinical features |
Q42249529 | Mammary herpes: a little known mode of neonatal herpes contamination |
Q33939725 | Management of neonatal herpes simplex virus infection |
Q45830234 | Management of oral and genital herpes simplex virus infections: diagnosis and treatment |
Q40604634 | Management of the abnormal Papanicolaou smear |
Q34354915 | Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry |
Q44512626 | Maternal Herpes simplex virus type 2 encephalitis following Cesarean section |
Q27347896 | Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital Mucosa |
Q46689697 | Meningitis after locoregional spinal anesthesia |
Q45365651 | Mollaret's meningitis and herpes simplex virus type 2 infections |
Q37904038 | Monoclonal antibodies for the diagnosis of sexually transmitted diseases. |
Q34279175 | Mucosal host immune response predicts the severity and duration of herpes simplex virus-2 genital tract shedding episodes |
Q40521461 | Multicenter evaluation of the Luminex® ARIES® HSV 1&2 Assay for the detection of herpes simplex virus types 1 and 2 in cutaneous and mucocutaneous lesion specimens |
Q39562986 | Natural history and pathogenesis of neonatal herpes simplex virus infections |
Q35545367 | Neonatal herpes simplex infection |
Q73214960 | Neonatal herpes simplex virus infection |
Q70235875 | Neonatal herpes simplex virus infections |
Q45732154 | Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients |
Q41919381 | Neurovirulence of herpes simplex virus types 1 and 2 isolates in diseases of the central nervous system |
Q33815811 | Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro |
Q33582145 | New concepts in understanding genital herpes |
Q26746041 | Optimal management of genital herpes: current perspectives |
Q30991218 | Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials |
Q35562031 | Oral sex and the transmission of viral STIs |
Q30582561 | Overview of acute and chronic meningitis |
Q44204372 | Painless primary herpes |
Q37419798 | Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans |
Q37059518 | Performance of the Focus and Kalon Enzyme-Linked Immunosorbent Assays for Antibodies to Herpes Simplex Virus Type 2 Glycoprotein G in Culture-Documented Cases of Genital Herpes |
Q40903260 | Perinatal herpesvirus infections. Herpes simplex, varicella, and cytomegalovirus |
Q37295563 | Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition |
Q34682912 | Persistent genital herpes simplex virus-2 shedding years following the first clinical episode |
Q35543240 | Pharmacokinetics of acyclovir suspension in infants and children |
Q69912315 | Placebo-controlled trial of topical interferon in labial and genital herpes |
Q35236237 | Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection |
Q35572847 | Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic |
Q37201714 | Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa |
Q36173112 | Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females |
Q24670332 | Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia |
Q39848661 | Prevalence of HSV-2 antibody in a Melbourne antenatal population attending a tertiary obstetric hospital |
Q38933575 | Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil |
Q33932926 | Preventing neonatal herpes? |
Q57004506 | Prevention and control of herpesvirus diseases. Part 2. Epidemiology and immunology |
Q37450218 | Prevention of genital herpes simplex virus type 1 and 2 disease in mice immunized with a gD-expressing dominant-negative recombinant HSV-1. |
Q59354827 | Primary Herpes Simplex Virus Infection Mimicking a Cervical Malignancy in an Immunocompetent Individual |
Q35698595 | Primary herpes simplex virus infection mimicking cervical cancer |
Q44644151 | Proinflammatory cytokines and chemokines - but not interferon-β - produced in response to HSV-2 in primary human genital epithelial cells are associated with viral replication and the presence of the virion host shutoff protein |
Q72586720 | Properties of antiviral agents. 1 |
Q37547107 | Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs |
Q36090597 | Psychological symptoms associated with genital herpes virus infections: epidemiology and approaches to management. |
Q37939941 | Psychosocial aspects of genital herpes: a review of the literature |
Q40839973 | Psychosocial factors and recurrent genital herpes: a review of prediction and psychiatric treatment studies |
Q33931849 | Psychosocial implications of recurrent genital herpes simplex virus infection |
Q37265201 | Rapid diagnosis of herpes simplex virus infections by enzyme-linked immunosorbent assay |
Q37694574 | Rapid host immune response and viral dynamics in herpes simplex virus-2 infection |
Q36624531 | Rapid immunoassay for the detection of genital herpes infection |
Q36776541 | Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract |
Q33963713 | Recent progress in herpes simplex virus immunobiology and vaccine research |
Q34959913 | Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro |
Q37052019 | Reconsideration of viral protein immunoblotting for differentiation of human herpes simplex viruses |
Q45807606 | Recovery of Epstein–Barr Virus from Genital Ulcers |
Q33931593 | Recurrent genital herpes: clinical and virological features in men and women |
Q33932337 | Recurrent genital tract infection: a result of induced immunosuppression? |
Q37929715 | Recurrent intra-oral herpes simplex 1 infection |
Q28375900 | Resveratrol inhibition of herpes simplex virus replication |
Q35562163 | Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes |
Q39741173 | Screening therapeutic insemination donors for sexually transmitted diseases: overview and recommendations |
Q33583162 | Screening to detect asymptomatic shedding of herpes simplex virus (HSV) in women with recurrent genital HSV infection. |
Q37221265 | Secreted herpes simplex virus-2 glycoprotein G alters thermal pain sensitivity by modifying NGF effects on TRPV1. |
Q33931901 | Secretory IgA against herpes simplex virus in cervical secretions. |
Q41206252 | Selected issues in premature rupture of the membranes: herpes, cerclage, twins, tocolysis, and hospitalization |
Q45730664 | Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection |
Q33917477 | Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya |
Q37233274 | Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G |
Q41753569 | Serum HSV-1 and -2 IgM in pregnant women in Port Harcourt, Nigeria |
Q36151979 | Severe Primary HSV-2 in a Perinatal HIV-Infected Woman with Advanced Immunosuppression |
Q50950429 | Sexually Transmitted Infections. |
Q36520142 | Sexually transmitted cervicitis |
Q40828451 | Sexually transmitted diseases. Present problems-future prospects |
Q41703667 | Sexually transmitted esophagitis: primary herpes simplex virus type 2 infection in a healthy man. |
Q35733995 | Sexually transmitted herpes simplex viruses |
Q36987962 | Sexually transmitted viruses |
Q93080827 | Shedding of the Salmonid Herpesvirus-3 by Infected Lake Trout (Salvelinus namaycush) |
Q33973461 | Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population |
Q37206230 | Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy? |
Q45845315 | Susceptibility to acyclovir of herpes simplex virus: emergence of resistance in patients with lymphoid and myeloid neoplasia |
Q40544353 | Synthesis of aldehydo-sugar derivatives of pyrazoloquinoline as inhibitors of herpes simplex virus type 1 replication |
Q34092277 | The Acute Aseptic Meningitis Syndrome |
Q33934554 | The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. |
Q56561856 | The epidemiology of herpes simplex virus type 1 in Asia: systematic review, meta-analyses, and meta-regressions |
Q90577892 | The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study |
Q30842506 | The herpesvirus proteases as targets for antiviral chemotherapy |
Q35129410 | The kinetics of mucosal herpes simplex virus-2 infection in humans: evidence for rapid viral-host interactions |
Q34730907 | The role of oral acyclovir in the management of genital herpes simplex |
Q35540898 | Therapy of genital herpes with topically applied interferon |
Q45851405 | Three cases of neonatal herpes simplex virus infection presenting as fulminant hepatitis |
Q33583249 | Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): double blind, placebo controlled, multicentre study |
Q68105188 | Toward the rational management of herpes infection in pregnant women and their newborn infants. Infectious Diseases and Immunization Committee, Canadian Paediatric Society |
Q45238358 | Transmission of sexually transmitted diseases by donor semen |
Q44820361 | Treatment of first-attack genital herpes--acyclovir versus inosine pranobex |
Q45847830 | Treatment of herpes simplex virus infections. |
Q37859744 | Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum |
Q40076516 | Treatment of mucocutaneous herpes simplex infections |
Q36144195 | Type-specific screening for asymptomatic herpes infection in pregnancy: a decision analysis |
Q45738818 | Typing of herpes simplex virus from human periodontium |
Q67488109 | Underdiagnosis of Genital Herpes by Current Clinical and Viral-Isolation Procedures |
Q35169736 | Unusual initial presentation of herpes simplex virus as inguinal lymphadenopathy |
Q34868359 | Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision |
Q55406946 | Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs. |
Q91766368 | Vaccines to prevent genital herpes |
Q47189603 | Vagina dentata revisited: gender and asymptomatic shedding of genital herpes |
Q36413848 | Vaginal discharge: an approach to diagnosis and management |
Q64922869 | Vaginal infection of mice with HSV type 2 variant ER−: A new animal model for human primary genital HSV type 2 infections |
Q36520204 | Vaginal infections. |
Q42277082 | Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients |
Q41460971 | Verbal intercourse and sexual communication: impediments to STD prevention |
Q24669976 | Viral meningitis |
Q30576590 | Virologic and immunologic evidence of multifocal genital herpes simplex virus 2 infection |
Q43047521 | Zika Virus Persistently and Productively Infects Primary Adult Sensory Neurons In Vitro |
Q50740943 | [An epidemiological model of genital herpes for assessment of potential impact of therapy and prophylaxis: application to France] |
Q79335121 | [Genital herpes] |
Q76341636 | [Primary genital herpes with sacral meningoradiculitis] |
Search more.